The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...
At a median follow-up of 12.3 months, 44% of patients with PTCL had an objective response by blinded independent central review in this study, with a median response duration of 11.9 months. Among ...
Mother-to-child HBV transmission was effectively prevented by earlier initiation of TDF prophylaxis in pregnancy combined with HBV vaccination at birth for infants.